Kyphoplasty Market Expected to Reach $1.2 Billion by 2031

The kyphoplasty market was valued at $632.45 million in 2021, and is estimated to reach $1.2 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031. Vertebral compression fracture (VCF) is a form of spinal disorder caused by the fracture of bones in the spinal cord as a result of osteoporosis, arthritis, or trauma. Kyphoplasty is one of the surgical options for treating this VCF. It commonly occurs in the vertebrae that have been weakened by osteoporosis or by other diseases. The fracture occurs when the bone has deteriorated to the point that it can no longer support the spine column in daily activities.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/16933

In Kyphoplasty, a needle is inserted into the spine bone via the skin. Real-time x-ray pictures help the doctor find the right spot in the lower back. A balloon is inserted into the bone through the needle; subsequently inflated and medical-grade bone cement is injected into that cavity. Bone cement, majorly consists of a liquid monomer and a copolymer powder, known as polymethylmethacrylate (PMMA). Hardening immediately, the cavity becomes stabilized by the substance. Thus, the height of the vertebrae is restored to prevent it from collapsing again. It is a generally safe procedure for restoring spinal height, correcting kyphosis deformity, and removing compression fracture discomfort.

Increase in the elderly population, surge in cases of osteoporosis & arthritis, and spine disorders are the major drivers of this market. Kyphoplasty is performed in cancer-damaged vertebrae, some spinal fractures, and also due to long-term steroid treatment or a metabolic disorder. In addition, it is a minimally invasive low risk procedure and has a short recovery time making it the safest treatment for VCF. In addition, higher adoption rate of sedentary lifestyles, loss of physical activity especially among aging individuals, upsurge in accidents and trauma increases chances of having Kyphoplasty. Furthermore, innovations, development of advanced technologies, key strategies adopted by the key players and increasing awareness for spinal treatments kyphoplasty market trends. However, post-surgery complications such as cement leakage, are expected to hinder the kyphoplasty industry growth. Conversely, increase in spinal disease load and rise in healthcare expenditure are great opportunities for key players to invest during the forecast period, especially in the developing economies.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/16933

Depending on end user, the market is divided into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment dominated the market in 2021, with $494.84 million, owing to increase in number of hospital admissions for vertebral compression fractures and accidental injuries to spinal cord. The ambulatory surgical centers segment is expected to witness highest kyphoplasty market growth during the forecast period, owing to surge in osteoporosis diagnosis and demand for ASCs, owing to its specific care and comfortable settings for elderly.

North America accounted for a majority of the global kyphoplasty market size in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in kyphoplasty techniques, integration of advanced devices and software processes in kyphoplasty devices, presence of key and robust hospital infrastructure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in geriatric population, development of healthcare infrastructure and increase in investments projects in the region.

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

By product, the accessories segment was the highest contributor to the market in 2021, and is expected to continue this trend during the forecast period.

By indication, osteoporosis segment was the highest contributor to the market in 2021, and is expected to continue this trend during the forecast period.

Depending on end user, the hospital & clinics segment was highest contributor in 2021, and is expected to continue this trend during the forecast period.

Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.